About Us
Finding key to every biological lock
bioLOCKEY Healthworks is a multidisciplinary innovation lab currently pioneering the next generation of Smart, Point of care diagnostics focused towards women health. We are dedicated to deliver self-use, safe, affordable and ultrasensitive rapid diagnostic tests to significantly advance health and health care practices.
bioLOCKEY has developed a proprietary Nanobody discovery platform NANOdx. We have leveraged our knowledge of antigen-Nanobody molecular interactions to develop highly functional repertoires to surpass the diversity and functionality of the natural immune system. We have integrated these unique libraries within a yeast surface display system and optimized a high throughput methodology for the rapid discovery of Nanobodies to virtually any antigen/targets and their structure-guided optimization. We will also exploit NanoDx* to develop cell-based and virus-like particle antigen display methods for membrane-bound antigens.
Our vision is to bring in cutting edge, novel disruptive technologies in healthcare all the while keeping in mind affordability, accuracy and potency
Leadership & Advisors
bioLOCKEY Healthworks is a collaboration between Scientists, chemists and bio-engineers. This collaboration provides the opportunity for scientific theory to drive biotechnology advancement for optimal clinical outcomes via bio-engineered systems
-
Previous affiliation: MRC, UK; Stanford Bioengineering, USA; Max-Planck Institute,Germany
-
15 years of research experience in Small molecule therapeutics and drug Discovery
-
Expertise in Bioengineering, Molecular Imaging, Biological screening & Validation
-
Previous Affiliation: UCSF, CA, USA; Max-Planck Institute, Germany
-
20 years of research experience in Structural Biochemistry, crystallography
-
Expertise in Protein engineering, Nanobody based biologics discovery and development
-
Founder Cytokinetics Inc., MyoKardia Inc., Kainomyx Inc. & Cyntegron Therapeutics
-
Developed first FDA approved drug for cardiomyopathies with MyoKardia Inc.
-
Over 50 years of research experience in drug development
-
Founding Dean-instem, India
-
Founder/CEO- CCAMP, India
-
Over 40 years of research experience in Structural Biology, Biochemistry, Drug discovery
R&D Team
-
Education: BTech/ MTech Biotechnology
-
Experience in IVD testing
-
Previous Affiliation: Postdoctoral fellow-instem, Skanda Lifesciences/ Enzene Biosciences/ Jubilant Biosciences
-
Over 10 years of research experience in Antibody engineering, Cell-based biosimilars screening
-
Education: PhD-IIT Bombay
-
Previous Affiliation: Scientist-Mynvax, Postdoctoral fellow-MPI Dresden, inSTEM, Uni. Montreal,
-
Over 12 years of research experience in Preclinical Vaccine R&D, Yeast surface display based screening and library generation, RNA based sensors
-
Education: MSc Biotechnology-University of East London
-
Technical Officer- THSTI
-
Experience in Development and Optimization of multiplex vertical/ Lateral Flow Technology, In-vitro rapid diagnostic tests